quantic69/iStock via Getty Images
Alvotech (NASDAQ:ALVO) and Dr. Reddy’s Laboratories (NYSE:RDY) have entered into a collaboration and license agreement to co-develop, manufacture, and commercialize a biosimilar candidate to Keytruda (pembrolizumab) for global markets.
Keytruda (pembrolizumab) is indicated for the treatment of numerous cancer types. In 2024, worldwide sales
The Dow Jones Industrial Average finished down on Friday, while the S&P 500 ended largely unchanged, as investors' risk appetite...
The family of a homeless man who died after a bulldozer crushed his tent last year during an encampment sweep filed a...
The administration of U.S. President Donald Trump has canceled solar projects in Puerto Rico worth millions of dollars, as the island struggles...
Chinese officials have told the country's largest tech firms, including Alibaba Group, they can prepare orders for Nvidia H200 AI...
When U.S. President Donald Trump wasn’t stealing the show, the hottest topic of this year’s Davos summit was artificial intelligence....
Mumbai: States' consolidated fiscal deficit has widened to 3.3 per cent of GDP in FY25 after remaining at 3 per...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.
